97 related articles for article (PubMed ID: 7258825)
1. The role of immune complexes in the pathogenesis of pleural effusions.
Andrews BS; Arora NS; Shadforth MF; Goldberg SK; Davis JS
Am Rev Respir Dis; 1981 Aug; 124(2):115-20. PubMed ID: 7258825
[TBL] [Abstract][Full Text] [Related]
2. [Immunologic study of pleural neoplastic effusions: Detection of immune complexes and complement activation].
Kaelin R; Docquier C; Lew D; Carpentier N; Lambert PH; Waldvogel FA
Schweiz Med Wochenschr; 1978 Dec; 108(49):1971-3. PubMed ID: 749195
[TBL] [Abstract][Full Text] [Related]
3. Decreased heat-labile opsonic activity and complement levels associated with evidence of C3 breakdown products in infected pleural effusions.
Lew PD; Zubler R; Vaudaux P; Farquet JJ; Waldvogel FA; Lambert PH
J Clin Invest; 1979 Feb; 63(2):326-34. PubMed ID: 429556
[TBL] [Abstract][Full Text] [Related]
4. Pleural fluid complement, complement conversion, and immune complexes in immunologic and nonimmunologic diseases.
Hunder GG; McDuffie FC; Huston KA; Elveback LR; Hepper NG
J Lab Clin Med; 1977 Dec; 90(6):971-80. PubMed ID: 597373
[TBL] [Abstract][Full Text] [Related]
5. Immune complex vasculitis as a cause of ascites and pleural effusions in systemic lupus erythematosus.
Schocket AL; Lain D; Kohler PF; Steigerwald J
J Rheumatol; 1978; 5(1):33-8. PubMed ID: 147941
[TBL] [Abstract][Full Text] [Related]
6. Complement components and their activation products in pleural fluid.
Salomaa ER; Viander M; Saaresranta T; Terho EO
Chest; 1998 Sep; 114(3):723-30. PubMed ID: 9743157
[TBL] [Abstract][Full Text] [Related]
7. High levels of complement breakdown products in tuberculous pleural effusions.
Lew DP; Perrin LH; Vassalli JD; Suter S; Lambert PH; Waldvogel FA
Clin Exp Immunol; 1983 Jun; 52(3):569-74. PubMed ID: 6603298
[TBL] [Abstract][Full Text] [Related]
8. [Case of MCTD with recurrent pleuritis and high titers of anti-U1RNP antibody and immune complex in the pleural effusion].
Oshima N; Watanabe F; Mitsumori T; Yoshida T; Natsumura M; Kuwana M; Akizuki M
Nihon Naika Gakkai Zasshi; 1994 Aug; 83(8):1357-8. PubMed ID: 7983418
[No Abstract] [Full Text] [Related]
9. Prevalence of human immunodeficiency virus infection: its impact on the diagnostic yields in exudative pleural effusions at the Kenyatta National Hospital, Nairobi.
Owino EA; McLigeyo SO; Gathua SN; Nyong'o A
East Afr Med J; 1996 Sep; 73(9):575-8. PubMed ID: 8991236
[TBL] [Abstract][Full Text] [Related]
10. [The changes and clinical significance of interleukin 1 beta in pleural effusion].
Yang T; Han L; Wang B
Zhonghua Jie He He Hu Xi Za Zhi; 1995 Apr; 18(2):85-7, 127-8. PubMed ID: 7553957
[TBL] [Abstract][Full Text] [Related]
11. Identification of a tumor-related protein antigen in immune complexes derived from pleural effusions of patients with bronchial carcinoma.
Lawniczak M; Jezewska E; Górny MK; Zeromski J
Neoplasma; 1985; 32(1):9-20. PubMed ID: 3982564
[TBL] [Abstract][Full Text] [Related]
12. Autoantibodies to albumin in the plasma of patients with diabetes mellitus. Relationship with circulating immune complexes.
Triolo G; Giardina E; Rinaldi A; Seddio G; Bompiani GD
J Clin Lab Immunol; 1986 Nov; 21(3):113-5. PubMed ID: 3560190
[TBL] [Abstract][Full Text] [Related]
13. [Comparison of complement activation between tuberculous and malignant pleuritis].
Hidaka K; Abe M; Tanaka T; Mitsuyama T; Hara N; Hara N
Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Apr; 33(4):379-83. PubMed ID: 7791265
[TBL] [Abstract][Full Text] [Related]
14. In vitro production of leucocyte migration inhibitory factor by lymphocytes in exudative pleural effusions.
Pettersson T; Welin MG; Weber TH
J Clin Lab Immunol; 1982 Jun; 8(2):107-11. PubMed ID: 7050387
[TBL] [Abstract][Full Text] [Related]
15. Local immunotherapy with interferon-alpha in metastatic pleural and peritoneal effusions: correlation with immunologic parameters.
Stathopoulos GP; Baxevanis CN; Papadopoulos NG; Zarkadis IK; Papacostas P; Michailakis E; Tsiatas ML; Papamichail M
Anticancer Res; 1996; 16(6B):3855-60. PubMed ID: 9042270
[TBL] [Abstract][Full Text] [Related]
16. Serum and pleural fluid N-Terminal-Pro-B-Type natriuretic peptide concentrations in the differential diagnosis of pleural effusions.
Yorgancıoğlu A; Ozgen Alpaydın A; Yaman N; Taneli F; Bayturan O; Sakar Coşkun A; Celik P
Tuberk Toraks; 2011; 59(1):1-7. PubMed ID: 21554224
[TBL] [Abstract][Full Text] [Related]
17. Carcinoembryonic antigen (CEA) levels in pleural effusions and sera of lung cancer patients.
Ogushi F; Fukuoka M; Takada M; Tamai S; Sakai N; Negoro S; Okunaka N; Sone S; Tsubura E
Jpn J Clin Oncol; 1984 Sep; 14(3):321-7. PubMed ID: 6090732
[TBL] [Abstract][Full Text] [Related]
18. Use of pleural fluid C-reactive protein in laboratory diagnosis of pleural effusions.
Castaño Vidriales JL; Amores Antequera C
Eur J Med; 1992; 1(4):201-7. PubMed ID: 1341445
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic value of complement components in pleural fluid: report of 135 cases.
Shitrit D; Ollech JE; Ollech A; Peled N; Amital A; Fox B; Kramer MR
Respir Med; 2008 Nov; 102(11):1631-5. PubMed ID: 18653322
[TBL] [Abstract][Full Text] [Related]
20. Pentraxin-3: A novel biomarker for discriminating parapneumonic from other exudative effusions.
Ozsu S; Abul Y; Mentese A; Bektas H; Uzun A; Ozlu T; Porcel JM
Respirology; 2013 May; 18(4):657-62. PubMed ID: 23286371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
